Board Meeting

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE143.95-2.1 (-1.44 %)
PREV CLOSE ( ) 146.05
OPEN PRICE ( ) 145.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6905
TODAY'S LOW / HIGH ( )143.25 148.50
52 WK LOW / HIGH ( )113.55 202.2
NSE143.65-2.85 (-1.95 %)
PREV CLOSE( ) 146.50
OPEN PRICE ( ) 147.15
BID PRICE (QTY) 143.65 (145)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 87780
TODAY'S LOW / HIGH( ) 143.00 148.50
52 WK LOW / HIGH ( )114.2 202.5

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.